A Safety and Efficacy Study of T0903131 (INT131) Besylate to Treat Type 2 Diabetes Mellitus

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

NCT00478322 ·Status: COMPLETED ·Phase: PHASE2

Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise Alone

NCT07308184 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

NCT01455857 ·Status: COMPLETED ·Phase: PHASE3

A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes

NCT06567041 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes

NCT00856908 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

NCT02120976 ·Status: TERMINATED ·Phase: PHASE1

Single Ascending Dose Study of BMS-820132 in Patients With Type 2 Diabetes

NCT01105429 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

NCT02211261 ·Status: COMPLETED ·Phase: PHASE1

A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes

NCT01044017 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

NCT00513214 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus

NCT04606576 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

NCT00997152 ·Status: TERMINATED ·Phase: PHASE2

A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of JNJ-28431754 in Patients With Type 2 Diabetes Mellitus

NCT00963768 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus

NCT02175121 ·Status: COMPLETED ·Phase: PHASE2

A Phase 2 Study of Cyclo-Z in Subjects With Type 2 Diabetes

NCT03560271 ·Status: COMPLETED ·Phase: PHASE2

Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes

NCT02686281 ·Status: TERMINATED ·Phase: PHASE1

To Evaluate Safety and Tolerability After Multiple Oral Doses of AZD1656 in Type 2 Diabetes Patients on Top of Insulin

NCT00768105 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Safety, Tolerability, and Pharmacodynamic Effects of GLY-200 in Type 2 Diabetic Patients

NCT05478525 ·Status: COMPLETED ·Phase: PHASE2

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

NCT02183324 ·Status: COMPLETED ·Phase: PHASE2

Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects

NCT02106585 ·Status: COMPLETED ·Phase: PHASE1

Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With Metformin

NCT02135549 ·Status: COMPLETED ·Phase: NA

A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male Subjects

NCT03061981 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes

NCT01282970 ·Status: COMPLETED ·Phase: PHASE1

A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus

NCT01571661 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes

NCT02212925 ·Status: TERMINATED ·Phase: PHASE1